1[1]WHO,IPCS Environmental Health Criteria,Vol 155:Biomarks and Risk Ass essment:Concepts and Principle.Geneva,World Health Orgnization.1993.
2[2]Cullen MR,Redlich CA.Significance of individual sensitivity to chemi cal:elucidation of host susceptibility by use of biomarkers in environmental hea lth research.Clin Chem.1995,41(12Pt2)∶1809~1813.
3[3]Koh D,Jvaratnam J.Biomarkers,screening and ethics.Occup Med Oxf.1998 ,48(1)∶27~30.
4[4]Vainio H.Use of biomarkers-new frontiers in occupational toxicology and epidemiology.Toxicol Lett,1998,102-103∶581~589.
4Xie JM, Funakoshi T,Shimada H,et al. Effects of chelating agents on testicular toxicity in mice caused by acute exposure to nickel[J]. Toxicology,1995,103:147-154.
5Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissue by thiobarbituric acid test[J]. Anal Biochem,1978,86:271-278.
6Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent[ J]. J Biol Chem, 1952,193:265-267.
7Sole J, Huguet J. In vivo effects of nickel and cadmium in rats on lipid peroxidation and ceroloplamin activity[J]. Bull Environ Toxicol, 1990,44:686-689.
8Xie JM,Funakoshi T,Shimada H,et el. Comparative effects of chelating agents on pulmonary toxicity of systemic nickel in mice[J]. J Appl Toxicol,1996,16(4) :317-374.
9Cherian MG, Rodgers K. Chelation of cadmium form metallothionein in vivo and its excretion in rats repeatelly injected with cadmium chloride[J]. J Pharmacol Exp Ther,1982,4:699-702.
10Jones MM, Cherian MG. The research for chronic cadmium intoxification[J]. Toxicology, 1990,62:1-5.